Evidence map›Paper›PMID 42756340›Full record

ArticleFrontiers in immunology2026

A-to-I RNA editing profiles and distinct immune responses in myelin oligodendrocyte glycoprotein antibody-positive optic neuritis.

Xueqing Cui, Jianan Ding, Xuchu Fu, Fanli Cheng, Yutong Zhang, Wenjun Zou

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xueqing CuiDepartment of Ophthalmology, Jiangnan University Medical Center (JUMC), Wuxi, Jiangsu, China.
Jianan DingDepartment of Ophthalmology, Jiangnan University Medical Center (JUMC), Wuxi, Jiangsu, China.
Xuchu FuDepartment of Ophthalmology, Jiangnan University Medical Center (JUMC), Wuxi, Jiangsu, China.
Fanli ChengDepartment of Ophthalmology, Jiangnan University Medical Center (JUMC), Wuxi, Jiangsu, China.
Yutong ZhangDepartment of Ophthalmology, Jiangnan University Medical Center (JUMC), Wuxi, Jiangsu, China.
Wenjun ZouDepartment of Ophthalmology, Jiangnan University Medical Center (JUMC), Wuxi, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis (MOG-ON) is an autoimmune inflammatory demyelinating disorder of the optic nerve that often results in severe visual impairment and recurrent attacks. Although immune dysregulation is recognized as a central feature of MOG-ON, the contribution of post-transcriptional regulatory mechanisms, particularly adenosine-to-inosine (A-to-I) RNA editing, to disease pathogenesis and visual outcomes remains poorly understood. In this study, we characterized A-to-I RNA editing in MOG-ON, investigated molecular signatures and immune responses across the acute and remission phases, and explored candidate genes and associations with visual outcomes. Methods: A total of 14 peripheral blood samples were collected from patients with MOG-ON (9 in the acute phase and 5 in remission) and from 7 healthy controls. The A-to-I editome was characterized using RNA editing profiling, and stage-associated molecular signatures and immune responses were investigated using transcriptomic sequencing. In addition, functional enrichment analysis, immune pathway profiling, and estimated immune-cell proportions analysis were performed. Results: MOG-ON exhibited extensive A-to-I RNA editing remodeling, with 240 candidate differentially edited sites across 135 genes, predominantly enriched in neutrophil-mediated immunity and T-cell differentiation. Transcriptomic analysis revealed distinct stage-associated molecular programs: immunoglobulin production and B-cell receptor signaling were enriched during the acute phase, whereas cell cycle regulation was predominant during remission. CD74 and CDK1 were identified as candidate hub genes in the acute and remission phases, respectively. Furthermore, exploratory analyses suggested nominal associations of acute-phase BCVA with proportions of regulatory T cells and of CD74 expression with estimated neutrophil and monocyte proportions. Discussion: Collectively, these findings characterize RNA-editing alterations and stage-associated immune-transcriptomic features in MOG-ON and provide hypothesis-generating molecular candidates for further investigation.

Indexed as

AutoantibodiesMyelin-Oligodendrocyte GlycoproteinMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseOptic NeuritisRNA EditingAdenosineAdultFemaleGene Expression ProfilingHumansMaleMiddle AgedTranscriptomeAdenosineAutoantibodiesMOG protein, humanMyelin-Oligodendrocyte GlycoproteinA-to-I RNA editinggene expressionimmune responseinflammationMOG antibody-positive optic neuritis

Identifiers

PMID42756340
PMCPMC13582522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.